The price of Niraparib varies from different country versions. Generally speaking, its domestic price is about 6,000 yuan per box with the specification of 100mg x 30 capsules; the Indian version is about 19,100 yuan with the specification of 100mg*90 capsules; the Bangladesh Everest version is about 4,400 yuan with the specification of 100mg*30 capsules; and the Bangladesh Bikon version is about 12,500 yuan with the specification of 100mg*90 capsules. Niraparib is a novel ovarian cancer inhibitor drug, which functions and acts as an oral polyadenosine diphosphate ribose polymerase (PARP) 1/2 inhibitor that inhibits DNA repair. In clinical practice, niraparib is mainly used for the maintenance treatment of patients with advanced epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer after complete or partial remission to platinum-based chemotherapeutic agents. It should be noted that before taking niraparib for treatment, you must go to the hospital for detailed examination, and take it under the guidance of the doctor.